We are live on ! Find out more
RACB

Research Alliance Corp. II Class A Common Stock

Delisted

RACB was delisted on the 1st of December, 2022.

38 hedge funds and large institutions have $137M invested in Research Alliance Corp. II Class A Common Stock in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 12 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3838 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

6% less capital invested

Capital invested by funds: $147M → $137M (-$9.55M)

75% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 12

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
38
Holders Change
Holders Change %
0%
% of All Funds
0.66%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
2
Increased
3
Reduced
12
Closed
2
Calls
Puts
Net Calls
Net Calls Change

RACB Hedge Fund Activity: Q2 2021 in Review

38 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Research Alliance Corp. II Class A Common Stock (RACB) for Q2 2021, worth a combined $137M — down 6.5% from $147M a quarter earlier.

Fund positioning in RACB was balanced in Q2 2021: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 12 trimmed.

The largest buyer was HealthCor Management, adding an estimated $3.42M. The largest seller was Logos Global Management, cutting an estimated $2.11M.

  • 38 institutional investors held Research Alliance Corp. II Class A Common Stock (RACB) as of Q2 2021, unchanged from Q1 2021.
  • Funds reported $137M of Research Alliance Corp. II Class A Common Stock stock for Q2 2021, down 6.5% quarter-over-quarter.
  • 2 funds opened new Research Alliance Corp. II Class A Common Stock positions in Q2 2021 and 2 closed out, a net change of 0 holders.
  • The largest Research Alliance Corp. II Class A Common Stock buyer in Q2 2021 was HealthCor Management, an estimated $3.42M added.
  • The largest Research Alliance Corp. II Class A Common Stock seller in Q2 2021 was Logos Global Management, an estimated $2.11M sold.

Based on aggregated 13F filings for Q2 2021.